These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination. Dilraj A, Sukhoo R, Cutts FT, Bennett JV. Vaccine; 2007 May 22; 25(21):4170-4. PubMed ID: 17408818 [Abstract] [Full Text] [Related]
9. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus. Willis MF, Warburton MF. Med J Aust; 1974 May 18; 1(20):789-93. PubMed ID: 4853112 [No Abstract] [Full Text] [Related]
10. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines. Mirchamsy H, Shafyi A, Bahrami S, Kamali M, Nazari P. Dev Biol Stand; 1974 May 18; 37():297-300. PubMed ID: 1031692 [Abstract] [Full Text] [Related]
12. On the importance of the s marker in differentiation of attenuated and non-attenuated strains of measles virus. Khozinsky VI, Seybil VB, Panteleyeva NS, Shapovalova SM. Acta Virol; 1967 Sep 18; 11(5):432-5. PubMed ID: 4383026 [No Abstract] [Full Text] [Related]